|
1
|
Aherne SA and O'Brien NM: Dietary
flavonols: chemistry, food content, and metabolism. Nutrition.
18:75–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao J, Suzuki M, Jiang X, Chen X,
Yamamoto K, Ren F and Xu M: Influence of B-ring hydroxylation on
interactions of flavonols with bovine serum albumin. J Agric Food
Chem. 56:2350–2356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rogerio AP, Kanashiro A, Fontanari C, da
Silva EV, Lucisano-Valim YM, Soares EG and Faccioli LH:
Anti-inflammatory activity of quercetin and isoquercitrin in
experimental murine allergic asthma. Inflamm Res. 56:402–408. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamson DW and Brignall MS: Antioxidants
and cancer, part 3: quercetin. Altern Med Rev. 5:196–208.
2000.PubMed/NCBI
|
|
5
|
Heo MY, Sohn SJ and Au WW:
Anti-genotoxicity of galangin as a cancer chemopreventive agent
candidate. Mutat Res. 488:135–150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Galli SJ, Grimbaldeston M and Tsai M:
Immunomodulatory mast cells: negative, as well as positive,
regulators of immunity. Nat Rev Immunol. 8:478–486. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hofseth LJ and Ying L: Identifying and
defusing weapons of mass inflammation in carcinogenesis. Biochim
Biophys Acta. 1765:74–84. 2006.
|
|
8
|
Leung DY: Atopic dermatitis: the skin as a
window into the pathogenesis of chronic allergic diseases. J
Allergy Clin Immunol. 96:302–319. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bieber T and Simon HU: Allergen-specific
immunotherapy: current concepts and future directions. Allergy.
66:709–712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akdis CA, Akdis M, Trautmann A and Blaser
K: Immune regulation in atopic dermatitis. Curr Opin Immunol.
12:641–646. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanno S, Shouji A, Tomizawa A, Hiura T,
Osanai Y, Ujibe M, Obara Y, Nakahata N and Ishikawa M: Inhibitory
effect of naringin on lipopolysaccharide (LPS)-induced endotoxin
shock in mice and nitric oxide production in RAW 264.7 macrophages.
Life Sci. 78:673–681. 2006. View Article : Google Scholar
|
|
12
|
Fujihara M, Muroi M, Tanamoto K, Suzuki T,
Azuma H and Ikeda H: Molecular mechanisms of macrophage activation
and deactivation by lipopolysaccharide: roles of the receptor
complex. Pharmacol Ther. 100:171–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schaeffer HJ and Weber MJ:
Mitogen-activated protein kinases: specific messages from
ubiquitous messengers. Mol Cell Biol. 19:2435–2444. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Longpré F, Garneau P, Christen Y and
Ramassamy C: Protection by EGb 761 against β-amyloid-induced
neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways
and inhibition of amyloid fibril formation. Free Radic Biol Med.
41:1781–1794. 2006. View Article : Google Scholar
|
|
16
|
Reber L, Vermeulen L, Haegeman G and
Frossard N: Ser276 phosphorylation of NF-kB p65 by MSK1 controls
SCF expression in inflammation. PLoS One. 4:e43932009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hiscott J, Kwon H and Génin P: Hostile
takeovers: viral appropriation of the NF-kappaB pathway. J Clin
Invest. 107:143–151. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gloire G, Legrand-Poels S and Piette J:
NF-kappaB activation by reactive oxygen species: fifteen years
later. Biochem Pharmacol. 72:1493–1505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleemann R, Verschuren L, Morrison M,
Zadelaar S, van Erk MJ, Wielinga PY and Kooistra T:
Anti-inflammatory, anti-proliferative and anti-atherosclerotic
effects of quercetin in human in vitro and in vivo models.
Atherosclerosis. 218:44–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jung YC, Kim ME, Yoon JH, Park PR, Youn
HY, Lee HW and Lee JS: Anti-inflammatory effects of galangin on
lipo-polysaccharide-activated macrophages via ERK and NF-κB pathway
regulation. Immunopharmacol Immunotoxicol. 36:426–432. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu YN, Zha WJ, Ma Y, Chen FF, Zhu W, Ge
A, Zeng XN and Huang M: Galangin attenuates airway remodelling by
inhibiting TGF-β1-mediated ROS generation and MAPK/Akt
phosphorylation in asthma. Sci Rep. 5:117582015. View Article : Google Scholar
|
|
22
|
Kang NJ, Han SC, Kang GJ, Koo DH, Koh YS,
Hyun JW, Lee NH, Ko MH, Kang HK and Yoo ES:
Diphlorethohydroxycarmalol inhibits interleukin-6 production by
regulating NF-κB, STAT5 and SOCS1 in lipopolysaccharide-stimulated
RAW264.7 cells. Mar Drugs. 13:2141–2157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
García-Lafuente A, Guillamón E, Villares
A, Rostagno MA and Martínez JA: Flavonoids as anti-inflammatory
agents: implications in cancer and cardiovascular disease. Inflamm
Res. 58:537–552. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karawajczyk A, Drgan V, Medic N, Oboh G,
Passamonti S and Novič M: Properties of flavonoids influencing the
binding to bilitranslocase investigated by neural network
modelling. Biochem Pharmacol. 73:308–320. 2007. View Article : Google Scholar
|
|
25
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alderton WK, Cooper CE and Knowles RG:
Nitric oxide synthases: structure, function and inhibition. Biochem
J. 357:593–615. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bogdan C: Nitric oxide and the immune
response. Nat Immunol. 2:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Giuliano F and Warner TD: Origins of
prostaglandin E2: involvements of cyclooxygenase (COX)-1
and COX-2 in human and rat systems. J Pharmacol Exp Ther.
303:1001–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JA, Song HY, Ju SM, Lee SJ, Kwon HJ,
Eum WS, Jang SH, Choi SY and Park JS: Differential regulation of
inducible nitric oxide synthase and cyclooxygenase-2 expression by
superoxide dismutase in lipopolysaccharide stimulated RAW 264.7
cells. Exp Mol Med. 41:629–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Möller B and Villiger PM: Inhibition of
IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases.
Springer Semin Immunopathol. 27:391–408. 2006. View Article : Google Scholar
|
|
31
|
Kwon HS, Park JH, Kim DH, Kim YH, Park
JHY, Shin HK and Kim JK: Licochalcone A isolated from licorice
suppresses lipopolysaccharide-stimulated inflammatory reactions in
RAW264.7 cells and endotoxin shock in mice. J Mol Med (Berl).
86:1287–1295. 2008. View Article : Google Scholar
|
|
32
|
Tak PP and Firestein GS: NF-kappaB: a key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang
K, Calderwood SK and Xiao X: The inhibition of LPS-induced
production of inflammatory cytokines by HSP70 involves inactivation
of the NF-kappaB pathway but not the MAPK pathways. Shock.
26:277–284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oeckinghaus A, Hayden MS and Ghosh S:
Crosstalk in NF-κB signaling pathways. Nat Immunol. 12:695–708.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Monasterio A, Urdaci MC, Pinchuk IV,
López-Moratalla N and Martínez-Irujo JJ: Flavonoids induce
apoptosis in human leukemia U937 cells through caspase- and
caspase-calpain-dependent pathways. Nutr Cancer. 50:90–100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Husain SR, Cillard J and Cillard P:
Hydroxyl radical scavenging activity of flavonoids. Phytochemistry.
26:2489–2491. 1987. View Article : Google Scholar
|
|
37
|
Heeba GH, Mahmoud ME and El Hanafy AA:
Anti-inflammatory potential of curcumin and quercetin in rats: role
of oxidative stress, heme oxygenase-1 and TNF-α. Toxicol Ind
Health. 30:551–560. 2014. View Article : Google Scholar
|
|
38
|
Campbell JK, King JL, Harmston M, Lila MA
and Erdman JW: Synergistic effects of flavonoids on cell
proliferation in Hepa-1c1c7 and LNCaP cancer cell lines. J Food
Sci. 71:S358–S363. 2006. View Article : Google Scholar
|
|
39
|
Harasstani OA, Moin S, Tham CL, Liew CY,
Ismail N, Rajajendram R, Harith HH, Zakaria ZA, Mohamad AS,
Sulaiman MR, et al: Flavonoid combinations cause synergistic
inhibition of proinflammatory mediator secretion from
lipopolysaccharide-induced RAW 264.7 cells. Inflamm Res.
59:711–721. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Turner PV, Brabb T, Pekow C and Vasbinder
MA: Administration of substances to laboratory animals: routes of
administration and factors to consider. J Am Assoc Lab Anim Sci.
50:600–613. 2011.
|
|
41
|
Leung DY: Atopic dermatitis: new insights
and opportunities for therapeutic intervention. J Allergy Clin
Immunol. 105:860–876. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arshad SH and Holgate S: The role of IgE
in allergen-induced inflammation and the potential for intervention
with a humanized monoclonal anti-IgE antibody. Clin Exp Allergy.
31:1344–1351. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Karki R, Jung MA, Kim KJ and Kim DW:
Inhibitory effect of Nelumbo nucifera (Gaertn.) on the development
of atopic dermatitis-like skin lesions in NC/Nga mice. Evid Based
Complement Alternat Med. 153568:2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Galli SJ and Tsai M: IgE and mast cells in
allergic disease. Nat Med. 18:693–704. 2012. View Article : Google Scholar : PubMed/NCBI
|
